Machine Learning Classifies Ferroptosis and Apoptosis Cell Death Modalities with TfR1 ImmunostainingMarch 18, 2022Characterization of a patient-derived variant of GPX4 and analysis of potential for precision therapyJanuary 01, 2022A roadmap to creating ferroptosis-based medicinesNovember 01, 2021Development of therapies for rare genetic disorders of GPX4: roadmap and opportunitiesOctober 23, 2021Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicityJune 24, 2021iPLA2 beta-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4June 15, 2021Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulationsJune 14, 2021Photon Upconversion Hydrogels for 3D OptogeneticsJune 04, 2021Ferroptosis: mechanisms, biology and role in diseaseApril 01, 2021Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsApril 01, 2021Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosisJanuary 01, 2021p21 can be a barrier to ferroptosis independent of p53September 30, 2020PaginationFirst page« FirstPrevious page‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9Next pageNext ›Last pageLast »